Intesa Sanpaolo CEO Carlo Messina wins top award from Extel

Carlo Messina Managing Director and Chief Executive Officer of Intesa Sanpaolo Intesa Sanpaolo
Carlo Messina Managing Director and Chief Executive Officer of Intesa Sanpaolo - Intesa Sanpaolo
0Comments

Carlo Messina, CEO of Intesa Sanpaolo, has been named “Best Chief Executive Officer” in European banking for the eighth time in the 2025 Extel ranking. This accolade follows his recent recognition as “European Banker of the Year 2024” by The Group of 20+1, a Frankfurt-based association of financial journalists.

The Extel ranking is determined by votes from institutional investors and financial analysts. In addition to Messina’s achievement, Intesa Sanpaolo has been recognized as Europe’s top bank for investor relations and ESG performance. The bank’s Board of Directors was also acknowledged as the Best Company Board in European banking for the fourth consecutive year.

Luca Bocca, who became Chief Financial Officer in April 2024, was voted Best CFO. Marco Delfrate was recognized as Best Investor Relations Professional for the eighth consecutive year. Under the leadership of Delfrate and Andrea Tamagnini, Intesa Sanpaolo’s Investor Relations team was ranked best in European banking once again.

Intesa Sanpaolo has maintained its position at the forefront of ESG programs among European banks for six years running. This reflects their strategy and commitment to innovation, social impact, and sustainability.

The rankings are based on a survey conducted by Extel involving approximately 1,750 institutional investors and financial analysts. Extel is known for its independent research over more than five decades.

Carlo Messina commented on these achievements: “The continued recognition of Intesa Sanpaolo’s leadership in Europe is a source of immense satisfaction and pride. This is above all thanks to our clear and successful strategy, our solidity and profitability that allow us to succeed in any scenario… We believe that transparency and responsible communications are vital to our ongoing engagement with all our stakeholders.”



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.